Evidence map›Paper›PMID 36714105›Full record

ArticleFrontiers in medicine2022

Case report: Application of metagenomic next-generation sequencing in the diagnosis of visceral leishmaniasis and its treatment evaluation.

Qiuping Liang, Xiaogong Liang, Dengwei Hong, Yuan Fang, Lanlan Tang, Jiao Mu, Xiaoli Tan, Feng Chen

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Infection ofCase reports in gastroenterology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Qiuping LiangDepartment of Respiratory and Critical Care Medicine, The Third People's Hospital of Chengdu, Chengdu, China.
Xiaogong LiangDepartment of Hematopathology, Mianyang Central Hospital, Mianyang, China.
Dengwei HongGenoxor Medical Science and Technology Inc., Shanghai, China.
Yuan FangGenoxor Medical Science and Technology Inc., Shanghai, China.
Lanlan TangDepartment of Respiratory and Critical Care Medicine, The Third People's Hospital of Chengdu, Chengdu, China.
Jiao MuDepartment of Respiratory and Critical Care Medicine, The Third People's Hospital of Chengdu, Chengdu, China.
Xiaoli TanGenoxor Medical Science and Technology Inc., Shanghai, China.
Feng ChenDepartment of Respiratory and Critical Care Medicine, The Third People's Hospital of Chengdu, Chengdu, China.
Chengdu Third People's Hospital · CNMianyang Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Visceral leishmaniasis is a vector-borne infection by the

Indexed as

caseLeishmaniamNGStreatment efficacyvisceral leishmaniasis

Identifiers

PMID36714105
PMCPMC9880153
OpenAlexW4315782478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.